The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic Databases
Open accessAbstract
OBJECTIVE: To propose a unifying set of definitions for prescription adherence research utilizing electronic health record prescribing databases, prescription dispensing databases, and pharmacy claims databases and to provide a conceptual framework to operationalize these definitions consistently across studies. METHODS: We reviewed recent literature to identify definitions in electronic database studies of prescription-filling patterns for chronic oral medications. We then develop a conceptual model and propose standardized terminology and definitions to describe prescription-filling behavior from electronic databases. RESULTS: The conceptual model we propose defines 2 separate constructs: medication adherence and persistence. We define primary and secondary adherence as distinct subtypes of adherence. Metrics for estimating secondary adherence are discussed and critiqued, including a newer metric (New Prescription Medication Gap measure) that enables estimation of both primary and secondary adherence. DISCUSSION: Terminology currently used in prescription adherence research employing electronic databases lacks consistency. We propose a clear, consistent, broadly applicable conceptual model and terminology for such studies. The model and definitions facilitate research utilizing electronic medication prescribing, dispensing, and/or claims databases and encompasses the entire continuum of prescription-filling behavior. CONCLUSION: Employing conceptually clear and consistent terminology to define medication adherence and persistence will facilitate future comparative effectiveness research and meta-analytic studies that utilize electronic prescription and dispensing records.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220 · cited 4×
“Adherence connotes the degree or extent to which the patient conforms to the medication use recommendations specified by the prescriber (eg, frequency/interval of administration, time of day ingested, strength of dosage).(20) In contrast, persistence encompasses the time over which a patient continues treatment or con…”
BackgroundResultInfluentialA new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,193
Self-citationHess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 756
Self-citationA Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
Peterson, A. M., Nau, D. P., Cramer, J. A., Benner, J., Gwadry-Sridhar, F., & Nichol, M. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00139.x · Cited by 633
Comparison of drug adherence rates among patients with seven different medical conditions
Briesacher, B. A., Andrade, S. E., Fouayzi, H., & Chan, K. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.4.437 · Cited by 587
Comparing Adherence and Persistence Across 6 Chronic Medication Classes
Yeaw, J., Benner, J. S., Walt, J. G., Sian, S., & Smith, D. B. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.9.728 · Cited by 549
Huybrechts, K. F., Ishak, K. J., & Caro, J. J. (2006) · Bone · doi:10.1016/j.bone.2005.10.022 · Cited by 346
Early discontinuation of tamoxifen: A Lesson for oncologists
Barron, T. I., Connolly, R., Bennett, K., Feely, J., & Kennedy, M. J. (2007) · Cancer · doi:10.1002/cncr.22485 · Cited by 279
Cited by
Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management
Burnier, M., & Egan, B. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313220 · Cited by 878
An overview of the common methods used to measure treatment adherence
Anghel, L. A., Farcas, A. M., & Oprean, R. N. (2019) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1201 · Cited by 335
“This requires the existence of a centralized, electronic system with consistency among prescribers and dispensers, and can be a convenient and inexpensive method to measure adherence [14,15,20].”
BackgroundMethodGandapur, Y., Kianoush, S., Kelli, H. M., Misra, S., Urrea, B., Blaha, M. J., Graham, G., Marvel, F. A., & Martin, S. S. (2016) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcw018 · Cited by 202
Iglay, K., Cartier, S. E., Rosen, V. M., Zarotsky, V., Rajpathak, S. N., Radican, L., & Tunceli, K. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1053048 · Cited by 157
1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2021
Association, A. D. (2021) · Diabetes Care · doi:10.2337/dc21-s001 · Cited by 124
Drug adherence in hypertension: from methodological issues to cardiovascular outcomes
Hamdidouche, I., Jullien, V., Boutouyrie, P., Billaud, E., Azizi, M., & Laurent, S. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001299 · Cited by 111
Patient-Driven Diabetes Care of the Future in the Technology Era
Ashrafzadeh, S., & Hamdy, O. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.005 · Cited by 111
The myths of medication adherence
Gellad, W. F., Thorpe, C. T., Steiner, J. F., & Voils, C. I. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4334 · Cited by 98
Self-citationEarly‐ and later‐stage persistence with antiobesity medications: A retrospective cohort study
Gasoyan, H., Pfoh, E. R., Schulte, R., Le, P., & Rothberg, M. B. (2024) · Obesity · doi:10.1002/oby.23952 · Cited by 94
50 Years of Topical Retinoids for Acne: Evolution of Treatment
Baldwin, H., Webster, G., Stein Gold, L., Callender, V., Cook-Bolden, F. E., & Guenin, E. (2021) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00594-8 · Cited by 82
One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice
Gasoyan, H., Pfoh, E. R., Schulte, R., Le, P., Butsch, W. S., & Rothberg, M. B. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.33326 · Cited by 71
Persistence of newer anti-obesity medications in a real-world setting
Ganguly, R., Tian, Y., Kong, S. X., Hersloev, M., Hobbs, T., Smolarz, B. G., Ramasamy, A., Haase, C. L., & Weng, W. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.017 · Cited by 68
Giugliano, D., Longo, M., Caruso, P., Di Fraia, R., Scappaticcio, L., Gicchino, M., Petrizzo, M., Bellastella, G., Maiorino, M. I., & Esposito, K. (2021) · Diabetes Care · doi:10.2337/dc20-2623 · Cited by 69
Gasoyan, H., Butsch, W. S., Schulte, R., Casacchia, N. J., Le, P., Boyer, C. B., Griebeler, M. L., Burguera, B., & Rothberg, M. B. (2025) · Obesity · doi:10.1002/oby.24331 · Cited by 54
“previous supply and next dispense or between exhaustion of last supply and end of study follow-up [16].”
Rana, J. S., Virani, S. S., Moffet, H. H., Liu, J. Y., Coghlan, L. A., Vasadia, J., Ballantyne, C. M., & Karter, A. J. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.11.011 · Cited by 35
Self-citationUsing Dispensing Data to Evaluate Adherence Implementation Rates in Community Pharmacy
Torres-Robles, A., Wiecek, E., Cutler, R., Drake, B., Benrimoj, S. I., Fernandez-Llimos, F., & Garcia-Cardenas, V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00130 · Cited by 33
Safety, adherence and efficacy of PCSK9 inhibitors: a retrospective real-world study
Chng, B. L. K., Heng, W. M. P., Soon, Y. M., Hon, J. S., Lau, Y. H., Tan, R. S., & Tan, J. W. C. (2022) · Proceedings of Singapore Healthcare · doi:10.1177/20101058221144115 · Cited by 11
Alexander, G. C., Xu, Y., Xiao, X., Lewis, S. V., Zeger, S., & Mehta, H. B. (2026) · Obesity · doi:10.1002/oby.70076 · Cited by 1
“We considered prescriptions written within 3 days of one another as duplicate transactions, while in all other cases, we allowed for indefinite stockpiling when calculating whether or not pills were on hand [20].”
Toda, N., Haldar, T., Teerlink, C. C., Hu, D., Danilov, P., Huntsman, S., Lu, M., Tsao, P. S., Tcheandjieu, C., Iribarren, C., et al. (2026) · doi:10.64898/2026.01.06.26343530
Metadata
- Authors
- Raebel, M. A., Schmittdiel, J., Karter, A. J., Konieczny, J. L., & Steiner, J. F.
- Venue
- Medical Care
- Published
- 2013-08
- Volume
- 51
- Issue
- Supplement 8Suppl 3
- Pages
- S11-S21
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W2014390724
- Cited by
- 485
- References
- 31
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.